Scantox is one of Europe’s leading preclinical GLP-accredited preclinical CROs. From our four business units we cover a vast portfolio of services within the drug development process: Discovery (incl. Neuropharmacology), Genetic Toxicology, Regulatory Toxicology and Pharmaceutical Dev & Analytical.
Scantox is headquartered in Denmark, with subsidiaries in Sweden, Denmark, UK and Austria.
In vivo services include: Exploratory toxicology; Pharmacokinetics; Efficacy models; Local tolerance studies; General toxicology; Juvenile studies; Genotox; Embryofetal studies; Medical devices; Histopathology incl. scanning; Clinical pathology incl. biomarkers; Bioanalysis; Imaging; Safety Pharmacology; Wound healing.